EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Significant oligodendrocyte progenitor and microglial cell death is a feature of remyelination following toxin-induced experimental demyelination

Hallie Gaitsch, Peggy Assinck, Penelope Dimas, Chao Zhao, Laura Morcom, David H Rowitch, Daniel S Reich iD, Robin J M Franklin

Brain Communications · 2024-12-24 · 7 (1)

DOI: 10.1093/braincomms/fcae386 ↗

At a glance

Journal article in Brain Communications, published online on 2025-01-17. Written by Hallie Gaitsch and 7 co-authors. Institution: Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK. Cited 4 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY 4.0). Funded by: Wellcome Trust, Medical Research Council, NIGMS NIH HHS.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

The extent to which glial cell turnover features in successful remyelination is unclear. In this study, the rat caudal cerebellar peduncle-ethidium bromide lesion model was used to profile oligodendroglial and microglial/macrophage cell death and proliferation dynamics over the course of repair. Lesioned and control tissue was co-labelled with antibody markers for cell identity, proliferation, and apoptosis (TUNEL assay), then imaged at full thickness using confocal microscopy and quantified using custom CellProfiler pipelines. Early remyelination time points were marked by an increased density of total proliferating cells, including oligodendrocyte progenitor cells. Late remyelination time points featured increased TUNEL+ oligodendrocyte progenitor cells: however, most TUNEL+ cells within remyelinating lesions were Iba1+ microglia/macrophages. These results indicate that repairing lesions are characterized by a high degree of glial cell death and suggest that monitoring cell death-related by-products might have clinical value in the setting of remyelination.

Subjects

Author keywords

cell deathmicrogliaoligodendrocyteoligodendrocyte progenitor cellremyelination

Authors and institutions

  • Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK.
  • Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
  • Altos Labs, Cambridge Institute of Science, Cambridge CB21 6GQ, UK.
  • Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.

ORCID profiles: Daniel S Reich

Funding

  • Wellcome Trust
  • Medical Research Council
  • NIGMS NIH HHS
  • Intramural Research Program
  • National Institute of Neurological Disorders and Stroke
  • Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
  • Canadian Institutes of Health Research

Cite

APA

Gaitsch, H., Assinck, P., Dimas, P., Zhao, C., Morcom, L., Rowitch, D. H., Reich, D. S., & Franklin, R. J. M. (2024). Significant oligodendrocyte progenitor and microglial cell death is a feature of remyelination following toxin-induced experimental demyelination. Brain Communications, 7(1). https://doi.org/10.1093/braincomms/fcae386

Vancouver

Gaitsch H, Assinck P, Dimas P, Zhao C, Morcom L, Rowitch DH, et al. Significant oligodendrocyte progenitor and microglial cell death is a feature of remyelination following toxin-induced experimental demyelination. Brain Communications. 2024;7(1). doi:10.1093/braincomms/fcae386

BibTeX
@article{Gaitsch2024,
  author = {Gaitsch, Hallie and Assinck, Peggy and Dimas, Penelope and Zhao, Chao and Morcom, Laura and Rowitch, David H and Reich, Daniel S and Franklin, Robin J M},
  title = {Significant oligodendrocyte progenitor and microglial cell death is a feature of remyelination following toxin-induced experimental demyelination},
  journal = {Brain Communications},
  year = {2024},
  volume = {7},
  number = {1},
  doi = {10.1093/braincomms/fcae386}
}
Start for free →